Ibrutinib-Induced Paronychia and Periungual Pyogenic Granuloma

Nail changes elicited by Ibrutinib are relatively infrequent but are reported in the literature. Herein, we report on two cases that developed Ibrutinib-induced nail toxicities. A 63-year-old female, with relapsing mantle cell lymphoma on Ibrutinib 560mg/day for seven months developed paronychia, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamri, Awadh, Alghamdi, Yara, Alghamdi, Atheer, Albogami, Dhai B, Shahada, Omar, AlHarbi, Aseel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874258/
https://www.ncbi.nlm.nih.gov/pubmed/36712781
http://dx.doi.org/10.7759/cureus.32943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874258/
https://www.ncbi.nlm.nih.gov/pubmed/36712781
http://dx.doi.org/10.7759/cureus.32943

Ejemplares similares